CJC-1295 with DAC 5MG

CJC-1295 with DAC 5MG — Reliable Growth Hormone Research Peptide for Advanced Laboratory Studies

Product Overview

CJC-1295 with DAC 5MG is a synthetic growth hormone releasing hormone (GHRH) analogue developed for advanced laboratory and scientific research applications. The inclusion of Drug Affinity Complex (DAC) technology is the defining characteristic of this compound — it extends the peptide’s half-life by facilitating albumin binding, enabling sustained receptor engagement that short-acting GHRH analogues cannot provide in a research setting.

This extended-activity profile makes CJC-1295 with DAC 5MG particularly valuable for laboratory studies requiring prolonged receptor stimulation models, comparative signalling duration analysis, and investigations into downstream GH pathway responses under controlled experimental conditions.

The 5MG quantity is suited to focused research protocols where precise compound management and batch traceability are essential. Manufactured under strict laboratory-grade quality standards and batch-tested for identity, purity, and stability before supply.

Supplied strictly for controlled scientific research. Not intended for human or veterinary use.

Key Benefits

• DAC technology enables extended albumin-binding activity — critical for research into sustained GHRH receptor stimulation models
• Distinct from CJC-1295 No DAC — allows direct comparative studies on signalling duration and receptor occupancy profiles
• High-purity laboratory-grade formulation ensures accurate, reproducible receptor binding and downstream signalling data
• 5MG quantity supports focused experimental protocols with precise compound traceability
• Full batch documentation covering identity, purity, and stability — ready for institutional sourcing requirements
• Stability-engineered packaging preserves compound integrity from dispatch through to laboratory storage

Features

• Compound type: Synthetic GHRH analogue research peptide with DAC
• Quantity: 5MG per unit
• Grade: Laboratory research-grade
• Form: Lyophilised powder
• Quality control: Batch-tested — identity, purity, and stability
• Packaging: Stability-preserving, light and moisture protected
• Intended use: Controlled in vitro and laboratory experimental use only

Why Choose CJC-1295 with DAC 5MG

The key distinction between CJC-1295 with DAC and its counterpart CJC-1295 No DAC lies in half-life and receptor engagement duration. Without DAC, the peptide acts over a short window. With DAC, albumin binding extends activity significantly — making it the preferred research tool for studies modelling sustained growth hormone axis stimulation or comparing pulsatile versus continuous GHRH receptor activity patterns.

For researchers building comparative endocrine signalling datasets, having both variants available at equivalent purity levels is essential for valid side-by-side analysis. Arma Peptides supplies CJC-1295 No DAC 10MG alongside this compound, enabling direct comparative protocols from a single consistent supplier.

Batch certificates covering identity, purity, and stability are available for every unit — standard practice that protects experimental integrity and satisfies most institutional sourcing documentation requirements.

For researchers exploring the broader GH axis, this compound is frequently studied alongside Ipamorelin 5MG and GHK-Cu 50MG to build comprehensive receptor interaction datasets. Authoritative background reading on GHRH receptor biology is available via PubMed — National Library of Medicine, NCBI Biotechnology Information, and EMBL-EBI.

Usage & Application

CJC-1295 with DAC 5MG is intended exclusively for use by qualified researchers within properly equipped laboratory environments. Typical research applications include:

• Growth hormone axis signalling studies — investigating receptor activation and downstream GH pathway responses under controlled conditions
• Half-life and receptor occupancy research — analysing how DAC-mediated albumin binding affects signalling duration compared to non-DAC analogues
• Comparative GHRH analogue studies — profiling CJC-1295 with DAC against CJC-1295 No DAC and other GHRH variants
• Endocrine communication modelling — studying peptide-receptor interaction dynamics within the hypothalamic-pituitary axis in vitro
• Peptide stability and binding kinetics — investigating albumin association and dissociation behaviour in laboratory assay systems

Storage: Store lyophilised compound at −20°C for long-term stability. Short-term storage at 4°C is acceptable when use is imminent. Avoid repeated freeze-thaw cycles. Protect from moisture and direct light. Once reconstituted, store at 4°C under sterile conditions and use within your protocol-defined timeframe.

Frequently Asked Questions

What is CJC-1295 with DAC 5MG used for in laboratory research?

CJC-1295 with DAC 5MG is used in controlled laboratory studies investigating growth hormone releasing hormone receptor activity, endocrine signalling pathways, and extended-activity peptide behaviour. The DAC component facilitates albumin binding, making it particularly useful for research into sustained GHRH receptor stimulation models. It is strictly for qualified laboratory use only — not approved for human or animal administration.

What is the difference between CJC-1295 with DAC and CJC-1295 No DAC in research?

CJC-1295 No DAC acts over a short window, closely mimicking the pulsatile nature of endogenous GHRH release. CJC-1295 with DAC binds to albumin via the DAC technology, extending its half-life substantially and providing sustained receptor engagement. For comparative research, both variants are available from Arma Peptides at equivalent purity levels, allowing direct side-by-side signalling duration studies.

Is a Certificate of Analysis available for CJC-1295 with DAC 5MG?

Yes. Every batch is tested for identity, purity, and stability. Visit the Certificate of Analysis page or contact Arma Peptides before ordering to obtain batch-specific documentation for your sourcing records.

What purity standard does CJC-1295 with DAC 5MG meet?

CJC-1295 with DAC 5MG is manufactured to high-purity laboratory-grade standards. For research intended for publication or institutional review, HPLC-verified purity of ≥98% is the accepted minimum. Confirm the exact figure from the batch Certificate of Analysis before committing the compound to your experimental protocol.

Can CJC-1295 with DAC 5MG be ordered alongside other research peptides?

Yes. Arma Peptides supplies a full range of laboratory-grade research compounds including CJC-1295 No DAC 10MG, Ipamorelin 5MG, and BPC 157 10MG. Free delivery applies on orders over £200.